H-FABP as a Biomarker in Transient Ischemic Attack

Daisy Guamán-Pilco,Elvira Chocano,Elena Palà,Marcel Lamana-Vallverdú,Anna Penalba,Paula García-Rodríguez,Marta Rubiera,Alejandro Bustamante,Àlex Rovira,Soledad Pérez-Sánchez,Leire Azurmendi,Sandrine Reymond,Jean-Charles Sánchez,Joan Montaner
DOI: https://doi.org/10.1007/s12265-024-10552-4
2024-08-21
Journal of Cardiovascular Translational Research
Abstract:The study investigates the utility of heart fatty-acid binding protein (H-FABP) in distinguishing TIA from mimics. Data from 175 patients from the StrokeChip multicenter study was retrospectively analyzed. H-FABP level was measured using a rapid point-of-care test. Findings revealed that H-FABP levels were higher in individuals with TIA compared to mimics [3.10 ng/mL (IQR 2.13–4.78) vs. 1.70 ng/mL (IQR 1.23–2.38)] ( p 1.85 ng/ml for H-FABP, age > 42.5 years, and baseline NIHSS > 3.5 had a 100% of sensitivity and 23.30% of specificity. The study suggests that H-FABP has potential as a TIA diagnostic biomarker. The rapid application of POCT's for H-FABP measurement supports its potential use in emergency departments and primary care settings.
cardiac & cardiovascular systems,medicine, research & experimental
What problem does this paper attempt to address?